Papp, K. A.; Blauvelt, A.; Flack, M.; Gu, Y.; Thompson, E. H. Clinical Responses in Patients With Moderate-to-Severe Plaque Psoriasis Following Withdrawal and Re-Treatment With Risankizumab or Switching from Ustekinumab to Risankizumab. J of Skin 2017, 1, s5.